Computational approach to characterize causative factors and molecular indicators of chronic wound inflammation

Journal of Immunology

Volumn 192, Issue 4, 2014, Pages 1824-1834

  Nagaraja, Sridevi ^a   Wallqvist, Anders ^a   Reifman, Jaques ^a   Mitrophanov, Alexander Y ^a  

^a U S ARMY MEDICAL RESEARCH AND MATERIEL COMMAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPUTER SIMULATION; HUMANS; INFLAMMATION; INTERLEUKIN-6; MACROPHAGES; NEUTROPHILS; PLATELET-DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA; WOUNDS AND INJURIES;

EID: 84894257687     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302481     Document Type: Article

References (88)

1. Medzhitov, R. 2008. Origin and physiological roles of inflammation. Nature 454: 428-435.
2. Nathan, C. 2002. Points of control in inflammation. Nature 420: 846-852.
3. Melnicoff, M. J., P. K. Horan, and P. S. Morahan. 1989. Kinetics of changes in peritoneal cell populations following acute inflammation. Cell. Immunol. 118: 178-191.
4. Wu, Q., Y. Feng, Y. Yang, W. Jingliu, W. Zhou, P. He, R. Zhou, X. Li, and J. Zou. 2004. Kinetics of the phenotype and function of murine peritoneal macrophages following acute inflammation. Cell. Mol. Immunol. 1: 57-62.
5. Kumar, R., G. Clermont, Y. Vodovotz, and C. C. Chow. 2004. The dynamics of acute inflammation. J. Theor. Biol. 230: 145-155.
6. Feghali, C. A., and T. M. Wright. 1997. Cytokines in acute and chronic inflammation. Front. Biosci. 2: d12-d26.
7. Dinarello, C. A. 2000. Proinflammatory cytokines. Chest 118: 503-508.
8. Opal, S. M., and V. A. DePalo. 2000. Anti-inflammatory cytokines. Chest 117: 1162-1172.
9. Loots, M. A., E. N. Lamme, J. Zeegelaar, J. R. Mekkes, J. D. Bos, and E. Middelkoop. 1998. Differences in cellular infiltrate and extracellular matrix of chronic diabetic and venous ulcers versus acute wounds. J. Invest. Dermatol. 111: 850-857.
10. Nathan, C., and A. Ding. 2010. Nonresolving inflammation. Cell 140: 871-882.
11. Hunter, P. 2012. The inflammation theory of disease. The growing realization that chronic inflammation is crucial in many diseases opens new avenues for treatment. EMBO Rep. 13: 968-970.
12. Khanna, S., S. Biswas, Y. Shang, E. Collard, A. Azad, C. Kauh, V. Bhasker, G. M. Gordillo, C. K. Sen, and S. Roy. 2010. Macrophage dysfunction impairs resolution of inflammation in the wounds of diabetic mice. PLoS ONE 5: e9539.
13. Roy, S., S. Biswas, S. Khanna, G. Gordillo, V. Bergdall, J. Green, C. B. Marsh, L. J. Gould, and C. K. Sen. 2009. Characterization of a preclinical model of chronic ischemic wound. Physiol. Genomics 37: 211-224.
14. Navarro-Xavier, R. A., J. Newson, V. L. Silveira, S. N. Farrow, D. W. Gilroy, and J. Bystrom. 2010. A new strategy for the identification of novel molecules with targeted proresolution of inflammation properties. J. Immunol. 184: 1516-1525.
15. Zhou, L. J., R. Matsui, and I. Ono. 2000. Development of a chronic skin defect model and a study of cytokine secretion using the model. Wound Repair Regen. 8: 304-318.
16. Bystrom, J., I. Evans, J. Newson, M. Stables, I. Toor, N. van Rooijen, M. Crawford, P. Colville-Nash, S. Farrow, and D. W. Gilroy. 2008. Resolutionphase macrophages possess a unique inflammatory phenotype that is controlled by cAMP. Blood 112: 4117-4127.
17. Wiegand, C., U. Schönfelder, M. Abel, P. Ruth, M. Kaatz, and U. C. Hipler. 2010. Protease and pro-inflammatory cytokine concentrations are elevated in chronic compared to acute wounds and can be modulated by collagen type I in vitro. Arch. Dermatol. Res. 302: 419-428.
18. Gohel, M. S., R. A. Windhaber, J. F. Tarlton, M. R. Whyman, and K. R. Poskitt. 2008. The relationship between cytokine concentrations and wound healing in chronic venous ulceration. J. Vasc. Surg. 48: 1272-1277.
19. Hawksworth, J. S., A. Stojadinovic, F. A. Gage, D. K. Tadaki, P. W. Perdue, J. Forsberg, T. A. Davis, J. R. Dunne, J. W. Denobile, T. S. Brown, and E. A. Elster. 2009. Inflammatory biomarkers in combat wound healing. Ann. Surg. 250: 1002-1007.
20. Trengove, N. J., H. Bielefeldt-Ohmann, and M. C. Stacey. 2000. Mitogenic activity and cytokine levels in non-healing and healing chronic leg ulcers. Wound Repair Regen. 8: 13-25.
21. Trengove, N. J., M. C. Stacey, S. MacAuley, N. Bennett, J. Gibson, F. Burslem, G. Murphy, and G. Schultz. 1999. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen. 7: 442-452.
22. Utz, E. R., E. A. Elster, D. K. Tadaki, F. Gage, P. W. Perdue, J. A. Forsberg, A. Stojadinovic, J. S. Hawksworth, and T. S. Brown. 2010. Metalloproteinase expression is associated with traumatic wound failure. J. Surg. Res. 159: 633-639.
23. Jin, Y. F., H. C. Han, J. Berger, Q. Dai, and M. L. Lindsey. 2011. Combining experimental and mathematical modeling to reveal mechanisms of macrophagedependent left ventricular remodeling. BMC Syst. Biol. 5: 60.
24. Li, N. Y., K. Verdolini, G. Clermont, Q. Mi, E. N. Rubinstein, P. A. Hebda, and Y. Vodovotz. 2008. A patient-specific in silico model of inflammation and healing tested in acute vocal fold injury. PLoS ONE 3: e2789.
25. Menke, N. B., J. W. Cain, A. Reynolds, D. M. Chan, R. A. Segal, T. M. Witten, D. G. Bonchev, R. F. Diegelmann, and K. R. Ward; Virginia Commonwealth University Reanimation, Engineering Shock Center, The Wound Healing Group. 2010. An in silico approach to the analysis of acute wound healing. Wound Repair Regen. 18: 105-113.
26. Mi, Q., B. Rivière, G. Clermont, D. L. Steed, and Y. Vodovotz. 2007. Agent-based model of inflammation and wound healing: insights into diabetic foot ulcer pathology and the role of transforming growth factor-beta1. Wound Repair Regen. 15: 671-682.
27. Nieman, G., D. Brown, J. Sarkar, B. Kubiak, C. Ziraldo, J. Dutta-Moscato, C. Vieau, D. Barclay, L. Gatto, K. Maier, et al. 2012. A two-compartment mathematical model of endotoxin-induced inflammatory and physiologic alterations in swine. Crit. Care Med. 40: 1052-1063.
28. Prince, J. M., R. M. Levy, J. Bartels, A. Baratt, J. M. Kane, III, C. Lagoa, J. Rubin, J. Day, J. Wei, M. P. Fink, et al. 2006. In silico and in vivo approach to elucidate the inflammatory complexity of CD14-deficient mice. Mol. Med. 12: 88-96.
29. Reynolds, A., J. Rubin, G. Clermont, J. Day, Y. Vodovotz, and G. Bard Ermentrout. 2006. A reduced mathematical model of the acute inflammatory response: I. Derivation of model and analysis of anti-inflammation. J. Theor. Biol. 242: 220-236.
30. Torres, A., T. Bentley, J. Bartels, J. Sarkar, D. Barclay, R. Namas, G. Constantine, R. Zamora, J. C. Puyana, and Y. Vodovotz. 2009. Mathematical modeling of posthemorrhage inflammation in mice: studies using a novel, computer-controlled, closed-loop hemorrhage apparatus. Shock 32: 172-178.
31. Waugh, H. V., and J. A. Sherratt. 2006. Macrophage dynamics in diabetic wound dealing. Bull. Math. Biol. 68: 197-207.
32. Waugh, H. V., and J. A. Sherratt. 2007. Modeling the effects of treating diabetic wounds with engineered skin substitutes. Wound Repair Regen. 15: 556-565.
33. Smith, A. M., J. A. McCullers, and F. R. Adler. 2011. Mathematical model of a three-stage innate immune response to a pneumococcal lung infection. J. Theor. Biol. 276: 106-116.
34. Pierce, G. F., T. A. Mustoe, J. Lingelbach, V. R. Masakowski, G. L. Griffin, R. M. Senior, and T. F. Deuel. 1989. Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms. J. Cell Biol. 109: 429-440.
35. Pai, R., H. Ha, M. A. Kirschenbaum, and V. S. Kamanna. 1996. Role of tumor necrosis factor-alpha on mesangial cell MCP-1 expression and monocyte migration: mechanisms mediated by signal transduction. J. Am. Soc. Nephrol. 7: 914-923.
36. Wang, J. M., B. Sherry, M. J. Fivash, D. J. Kelvin, and J. J. Oppenheim. 1993. Human recombinant macrophage inflammatory protein-1 alpha and -beta and monocyte chemotactic and activating factor utilize common and unique receptors on human monocytes. J. Immunol. 150: 3022-3029.
37. Deuel, T. F., R. M. Senior, J. S. Huang, and G. L. Griffin. 1982. Chemotaxis of monocytes and neutrophils to platelet-derived growth factor. J. Clin. Invest. 69: 1046-1049.
38. Wahl, S. M., D. A. Hunt, L. M. Wakefield, N. McCartney-Francis, L. M. Wahl, A. B. Roberts, and M. B. Sporn. 1987. Transforming growth factor type β induces monocyte chemotaxis and growth factor production. Proc. Natl. Acad. Sci. USA 84: 5788-5792.
39. Brandes, M. E., U. E. Mai, K. Ohura, and S. M. Wahl. 1991. Type I transforming growth factor-beta receptors on neutrophils mediate chemotaxis to transforming growth factor-beta. J. Immunol. 147: 1600-1606.
40. Byrne, A., and D. J. Reen. 2002. Lipopolysaccharide induces rapid production of IL-10 by monocytes in the presence of apoptotic neutrophils. J. Immunol. 168: 1968-1977.
41. Fadok, V. A., D. L. Bratton, A. Konowal, P. W. Freed, J. Y. Westcott, and P. M. Henson. 1998. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 101: 890-898.
42. Arnold, L., A. Henry, F. Poron, Y. Baba-Amer, N. van Rooijen, A. Plonquet, R. K. Gherardi, and B. Chazaud. 2007. Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis. J. Exp. Med. 204: 1057-1069.
43. Grainger, D. J., L. Wakefield, H. W. Bethell, R. W. Farndale, and J. C. Metcalfe. 1995. Release and activation of platelet latent TGF-beta in blood clots during dissolution with plasmin. Nat. Med. 1: 932-937.
44. Harpel, J. G., C. N. Metz, S. Kojima, and D. B. Rifkin. 1992. Control of transforming growth factor-beta activity: latency vs. activation. Prog. Growth Factor Res. 4: 321-335.
45. Andrei, C., C. Dazzi, L. Lotti, M. R. Torrisi, G. Chimini, and A. Rubartelli. 1999. The secretory route of the leaderless protein interleukin 1beta involves exocytosis of endolysosome-related vesicles. Mol. Biol. Cell 10: 1463-1475.
46. Hazuda, D. J., J. C. Lee, and P. R. Young. 1988. The kinetics of interleukin 1 secretion from activated monocytes. Differences between interleukin 1 alpha and interleukin 1 beta. J. Biol. Chem. 263: 8473-8479.
47. Newman, S. L., J. E. Henson, and P. M. Henson. 1982. Phagocytosis of senescent neutrophils by human monocyte-derived macrophages and rabbit inflammatory macrophages. J. Exp. Med. 156: 430-442.
48. Hart, S. P., K. M. Alexander, and I. Dransfield. 2004. Immune complexes bind preferentially to Fc gamma RIIA (CD32) on apoptotic neutrophils, leading to augmented phagocytosis by macrophages and release of proinflammatory cytokines. J. Immunol. 172: 1882-1887.
49. Ren, Y., Y. Xie, G. Jiang, J. Fan, J. Yeung, W. Li, P. K. Tam, and J. Savill. 2008. Apoptotic cells protect mice against lipopolysaccharide-induced shock. J. Immunol. 180: 4978-4985.
50. Mitrophanov, A. Y., G. Churchward, and M. Borodovsky. 2007. Control of Streptococcus pyogenes virulence: modeling of the CovR/S signal transduction system. J. Theor. Biol. 246: 113-128.
51. Wei, H., M. A. Nearing, and J. J. Stone. 2007. A comprehensive sensitivity analysis framework for model evaluation and improvement using a case study of the rangeland hydrology and erosion model. Trans. ASABE 50: 945-953.
52. Engelhardt, E., A. Toksoy, M. Goebeler, S. Debus, E. B. Bröcker, and R. Gillitzer. 1998. Chemokines IL-8, GROalpha, MCP-1, IP-10, and Mig are sequentially and differentially expressed during phase-specific infiltration of leukocyte subsets in human wound healing. Am. J. Pathol. 153: 1849-1860.
53. Yang, L., C. X. Qiu, A. Ludlow, M. W. Ferguson, and G. Brunner. 1999. Active transforming growth factor-β in wound repair: determination using a new assay. Am. J. Pathol. 154: 105-111.
54. Kum, W. W., S. B. Cameron, R. W. Hung, S. Kalyan, and A. W. Chow. 2001. Temporal sequence and kinetics of proinflammatory and anti-inflammatory cytokine secretion induced by toxic shock syndrome toxin 1 in human peripheral blood mononuclear cells. Infect. Immun. 69: 7544-7549.
55. Cao, C., D. A. Lawrence, D. K. Strickland, and L. Zhang. 2005. A specific role of integrin Mac-1 in accelerated macrophage efflux to the lymphatics. Blood 106: 3234-3241.
56. Sisco, M., J. D. Chao, I. Kim, J. E. Mogford, T. N. Mayadas, and T. A. Mustoe. 2007. Delayed wound healing in Mac-1-deficient mice is associated with normal monocyte recruitment. Wound Repair Regen. 15: 566-571.
57. Fillion, I., N. Ouellet, M. Simard, Y. Bergeron, S. Sato, and M. G. Bergeron. 2001. Role of chemokines and formyl peptides in pneumococcal pneumoniainduced monocyte/macrophage recruitment. J. Immunol. 166: 7353-7361.
58. Mori, R., T. Kondo, T. Ohshima, Y. Ishida, and N. Mukaida. 2002. Accelerated wound healing in tumor necrosis factor receptor p55-deficient mice with reduced leukocyte infiltration. FASEB J. 16: 963-974.
59. Brancato, S. K., and J. E. Albina. 2011. Wound macrophages as key regulators of repair: origin, phenotype, and function. Am. J. Pathol. 178: 19-25.
60. Gordon, S., and P. R. Taylor. 2005. Monocyte and macrophage heterogeneity. Nat. Rev. Immunol. 5: 953-964.
61. Koh, T. J., and L. A. DiPietro. 2011. Inflammation and wound healing: the role of the macrophage. Expert Rev. Mol. Med. 13: e23.
62. Mirza, R., L. A. DiPietro, and T. J. Koh. 2009. Selective and specific macrophage ablation is detrimental to wound healing in mice. Am. J. Pathol. 175: 2454-2462.
63. Lucas, T., A. Waisman, R. Ranjan, J. Roes, T. Krieg, W. Müller, A. Roers, and S. A. Eming. 2010. Differential roles of macrophages in diverse phases of skin repair. J. Immunol. 184: 3964-3977.
64. Hahm, G., J. J. Glaser, and E. A. Elster. 2011. Biomarkers to predict wound healing: the future of complex war wound management. Plast. Reconstr. Surg. 127(Suppl. 1): 21S-26S.
65. Crane, N. J., T. S. Brown, K. N. Evans, J. S. Hawksworth, S. Hussey, D. K. Tadaki, and E. A. Elster. 2010. Monitoring the healing of combat wounds using Raman spectroscopic mapping. Wound Repair Regen. 18: 409-416.
66. Forsberg, J. A., E. A. Elster, R. C. Andersen, E. Nylen, T. S. Brown, M. W. Rose, A. Stojadinovic, K. L. Becker, and F. X. McGuigan. 2008. Correlation of procalcitonin and cytokine expression with dehiscence of wartime extremity wounds. J. Bone Joint Surg. Am. 90: 580-588.
67. Chantry, D., M. Turner, E. Abney, and M. Feldmann. 1989. Modulation of cytokine production by transforming growth factor-beta. J. Immunol. 142: 4295-4300.
68. Maeda, H., H. Kuwahara, Y. Ichimura, M. Ohtsuki, S. Kurakata, and A. Shiraishi. 1995. TGF-beta enhances macrophage ability to produce IL-10 in normal and tumor-bearing mice. J. Immunol. 155: 4926-4932.
69. Tsunawaki, S., M. Sporn, A. Ding, and C. Nathan. 1988. Deactivation of macrophages by transforming growth factor-beta. Nature 334: 260-262.
70. Murray, P. J., and T. A. Wynn. 2011. Protective and pathogenic functions of macrophage subsets. Nat. Rev. Immunol. 11: 723-737.
71. Lawrence, T., and G. Natoli. 2011. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat. Rev. Immunol. 11: 750-761.
72. Daley, J. M., S. K. Brancato, A. A. Thomay, J. S. Reichner, and J. E. Albina. 2010. The phenotype of murine wound macrophages. J. Leukoc. Biol. 87: 59-67.
73. Jenkins, S. J., D. Ruckerl, P. C. Cook, L. H. Jones, F. D. Finkelman, N. van Rooijen, A. S. MacDonald, and J. E. Allen. 2011. Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science 332: 1284-1288.
74. Mosser, D. M., and J. P. Edwards. 2008. Exploring the full spectrum of macrophage activation. Nat. Rev. Immunol. 8: 958-969.
75. Fox, S., A. E. Leitch, R. Duffin, C. Haslett, and A. G. Rossi. 2010. Neutrophil apoptosis: relevance to the innate immune response and inflammatory disease. J. Innate Immun. 2: 216-227.
76. Gratchev, A., J. Kzhyshkowska, S. Kannookadan, M. Ochsenreiter, A. Popova, X. Yu, S. Mamidi, E. Stonehouse-Usselmann, I. Muller-Molinet, L. Gooi, and S. Goerdt. 2008. Activation of a TGF-beta-specific multistep gene expression program in mature macrophages requires glucocorticoid-mediated surface expression of TGF-beta receptor II. J. Immunol. 180: 6553-6565.
77. Oh, S. F., M. Dona, G. Fredman, S. Krishnamoorthy, D. Irimia, and C. N. Serhan. 2012. Resolvin E2 formation and impact in inflammation resolution. J. Immunol. 188: 4527-4534.
78. Ashley, N. T., Z. M. Weil, and R. J. Nelson. 2012. Inflammation: mechanisms, costs, and natural variation. Annu. Rev. Ecol. Evol. Syst. 43: 385-406.
79. Bryant, C. E., and T. P. Monie. 2012. Mice, men and the relatives: cross-species studies underpin innate immunity. Open Biol. 2: 120015.
80. Vane, J. R., and R. M. Botting. 1998. Mechanism of action of nonsteroidal anti-inflammatory drugs. Am. J. Med. 104 (Suppl. 1): 2S-8S; discussion 21S-22S.
81. Lewis, A. M., S. Varghese, H. Xu, and H. R. Alexander. 2006. Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment. J. Transl. Med. 4: 48.
82. Feldmann, M., and R. N. Maini. 2001. Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned? Annu. Rev. Immunol. 19: 163-196.
83. Teti, G., G. Mancuso, and F. Tomasello. 1993. Cytokine appearance and effects of anti-tumor necrosis factor alpha antibodies in a neonatal rat model of group B streptococcal infection. Infect. Immun. 61: 227-235.
84. Ashcroft, G. S., M. J. Jeong, J. J. Ashworth, M. Hardman, W. Jin, N. Moutsopoulos, T. Wild, N. McCartney-Francis, D. Sim, G. McGrady, et al. 2012. Tumor necrosis factor-alpha (TNF-α) is a therapeutic target for impaired cutaneous wound healing. Wound Repair Regen. 20: 38-49.
85. Thomay, A. A., J. M. Daley, E. Sabo, P. J. Worth, L. J. Shelton, M. W. Harty, J. S. Reichner, and J. E. Albina. 2009. Disruption of interleukin-1 signaling improves the quality of wound healing. Am. J. Pathol. 174: 2129-2136.
86. Wakefield, L. M., D. M. Smith, K. C. Flanders, and M. B. Sporn. 1988. Latent transforming growth factor-beta from human platelets. A high molecular weight complex containing precursor sequences. J. Biol. Chem. 263: 7646-7654.
87. Werner, S., and R. Grose. 2003. Regulation of wound healing by growth factors and cytokines. Physiol. Rev. 83: 835-870.
88. Bellingan, G. J., P. Xu, H. Cooksley, H. Cauldwell, A. Shock, S. Bottoms, C. Haslett, S. E. Mutsaers, and G. J. Laurent. 2002. Adhesion moleculedependent mechanisms regulate the rate of macrophage clearance during the resolution of peritoneal inflammation. J. Exp. Med. 196: 1515-1521.